锦波生物
(920982)
| 流通市值：95.91亿 | | | 总市值：201.01亿 |
| 流通股本：5490.51万 | | | 总股本：1.15亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,116,925,336.42 | 992,146,971.14 | 879,718,384.53 | 912,280,324.91 |
| 应收票据及应收账款 | 292,681,283.35 | 281,984,792.96 | 323,767,081.65 | 256,804,822.69 |
| 其中：应收票据 | - | - | 9,500,000 | 42,105,000 |
| 应收账款 | 292,681,283.35 | 281,984,792.96 | 314,267,081.65 | 214,699,822.69 |
| 应收款项融资 | - | - | - | 28,324,000 |
| 预付款项 | 38,746,089.8 | 29,012,519.38 | 36,096,556.8 | 40,817,543.52 |
| 其他应收款合计 | 5,387,840.23 | 5,249,353.24 | 7,373,589.16 | 7,743,263.84 |
| 存货 | 165,722,988.41 | 180,856,370.48 | 162,455,625.83 | 153,233,415.36 |
| 其他流动资产 | 9,266,339.35 | 7,938,103.67 | 7,847,013.67 | 7,914,283.89 |
| 流动资产合计 | 1,628,729,877.56 | 1,497,188,110.87 | 1,417,258,251.64 | 1,407,117,654.21 |
| 非流动资产: | | | | |
| 长期股权投资 | 597,536.96 | 597,536.96 | - | - |
| 其他非流动金融资产 | 30,000,000 | 30,000,000 | 30,000,000 | - |
| 固定资产 | 576,299,577.58 | 592,416,384.08 | 438,440,286.38 | 446,343,540.08 |
| 在建工程 | 85,361,816.66 | 73,081,650.75 | 227,498,431.52 | 188,087,300.46 |
| 使用权资产 | 76,447,735.9 | 80,598,419.63 | 84,595,983.16 | 82,979,139.25 |
| 无形资产 | 141,177,220.92 | 143,786,253.44 | 119,211,861.33 | 127,233,123.89 |
| 开发支出 | 102,614,621.53 | 93,909,816.72 | 87,004,261.41 | 58,845,193.42 |
| 长期待摊费用 | 26,667,340.54 | 19,983,027.29 | 16,851,474.52 | 17,782,921.92 |
| 递延所得税资产 | 19,246,513.58 | 19,002,910.82 | 19,191,651.28 | 16,844,667.73 |
| 其他非流动资产 | 23,800,437.97 | 33,291,206.77 | 22,174,654.05 | 21,709,188.08 |
| 非流动资产合计 | 1,082,212,801.64 | 1,086,667,206.46 | 1,044,968,603.65 | 959,825,074.83 |
| 资产总计 | 2,710,942,679.2 | 2,583,855,317.33 | 2,462,226,855.29 | 2,366,942,729.04 |
| 流动负债: | | | | |
| 短期借款 | 17,009,633.35 | 17,013,245.84 | - | - |
| 应付票据及应付账款 | 93,429,061.8 | 106,057,416.44 | 116,629,357.54 | 107,926,990.26 |
| 应付账款 | 93,429,061.8 | 106,057,416.44 | 116,629,357.54 | 107,926,990.26 |
| 合同负债 | 57,448,564.52 | 60,680,175.15 | 59,251,385.26 | 55,933,147.72 |
| 应付职工薪酬 | 29,796,818.68 | 32,839,964.37 | 33,099,262.92 | 35,477,986.8 |
| 应交税费 | 55,000,768.04 | 33,161,450.63 | 82,822,062.19 | 85,615,064.18 |
| 其他应付款合计 | 95,410,180.52 | 93,665,889.96 | 92,699,881.59 | 81,354,163.17 |
| 一年内到期的非流动负债 | 47,090,367.88 | 22,812,008.47 | 31,088,862.29 | 26,917,859.33 |
| 其他流动负债 | 3,442,275.48 | 3,878,401.82 | 3,828,416.29 | 5,615,924.65 |
| 流动负债合计 | 398,627,670.27 | 370,108,552.68 | 419,419,228.08 | 398,841,136.11 |
| 非流动负债: | | | | |
| 长期借款 | 154,122,587.5 | 182,110,755.56 | 64,304,745.72 | 74,609,116.26 |
| 租赁负债 | 68,541,368.67 | 82,415,624.7 | 82,633,980.47 | 78,773,340.09 |
| 递延收益 | 47,881,230.34 | 49,337,236.88 | 49,470,278.42 | 51,402,084.69 |
| 递延所得税负债 | 1,081,233.63 | 1,153,644.41 | 1,226,055.19 | 1,298,465.97 |
| 其他非流动负债 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| 非流动负债合计 | 276,626,420.14 | 320,017,261.55 | 202,635,059.8 | 211,083,007.01 |
| 负债合计 | 675,254,090.41 | 690,125,814.23 | 622,054,287.88 | 609,924,143.12 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 115,065,340 | 115,065,340 | 115,065,340 | 115,065,340 |
| 资本公积 | 289,689,271.29 | 289,689,271.29 | 320,202,825.03 | 300,812,351.33 |
| 盈余公积 | 57,532,670 | 57,532,670 | 44,255,900 | 44,255,900 |
| 未分配利润 | 1,573,421,541.1 | 1,432,966,575.23 | 1,362,387,723.65 | 1,301,237,656.97 |
| 归属于母公司股东权益合计 | 2,035,708,822.39 | 1,895,253,856.52 | 1,841,911,788.68 | 1,761,371,248.3 |
| 少数股东权益 | -20,233.6 | -1,524,353.42 | -1,739,221.27 | -4,352,662.38 |
| 股东权益合计 | 2,035,688,588.79 | 1,893,729,503.1 | 1,840,172,567.41 | 1,757,018,585.92 |
| 负债和股东权益合计 | 2,710,942,679.2 | 2,583,855,317.33 | 2,462,226,855.29 | 2,366,942,729.04 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-29 | 2025-08-11 |
| 审计意见(境内) | | 标准无保留意见 | | |